SOCS3 and metabolic disease: The results showed that SOCS3 was associated with benign tumors, cancers, nervous system diseases, respiratory or thoracic diseases, genetic diseases, endocrine system diseases, nutritional or metabolic diseases, immune system diseases, and gastrointestinal diseases (Figure 2D).